activity
serum
alpha
amylases
cystic
fibrosis
new
method
uses
differential
inhibitor
measure
pancreatic
salivary
type
alpha
amylases
ec
applied
serum
samples
cystic
fibrosis
cf
patients
age
range
years
controls
age
group
levels
pancreatic
type
amylase
lower
cf
patients
median
u
controls
median
p
less
results
salivary
type
enzyme
however
support
previously
reported
finding
higher
usual
levels
cf
patients
discrepancy
probably
due
differences
analytical
methods
felt
procedure
value
investigation
patients
cystic
fibrosis
pancreatic
disorders
